Considering Alternatives to Psychedelic Drug Prohibition
Beau Kilmer, Michelle Priest, Rajeev Ramchand, Rhianna C. Rogers, Ben Senator, Keytin Palmer
RAND Corporation eBooks 2024 DOI: 10.7249/rra2825-1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Report Peer reviewed |
|---|---|
| Citations | 4 |
| Key points | New data and analysis are presented to inform policy discussions about allowing adult nonclinical use of psychedelic substances. |
Abstract
Psychedelic substances, such as psilocybin and LSD, have long been touted as holding promise for treating some mental health conditions. An increasing number of U.S. state and local governments are implementing or considering alternative policies to prohibiting some of these substances for nonclinical purposes (i.e., adults can use them for any reason). The authors of this report present new data and analysis to inform these discussions.